PF-04217903

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-04217903, covering 2012-05-31 to 2012-05-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PF-04217903 in Patients With Advanced Cancer [Phase 1]